CN103705605B - Traditional Chinese medicine for treating leucoderma - Google Patents
Traditional Chinese medicine for treating leucoderma Download PDFInfo
- Publication number
- CN103705605B CN103705605B CN201310727750.4A CN201310727750A CN103705605B CN 103705605 B CN103705605 B CN 103705605B CN 201310727750 A CN201310727750 A CN 201310727750A CN 103705605 B CN103705605 B CN 103705605B
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese medicine
- traditional chinese
- radix
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating leucoderma. The traditional Chinese medicine is prepared from the following raw material medicines by weight: 90g of eclipta alba, 60g of Chinese angelica, 60g of radix angelicae, 45g of fructus psoraleae, 50g of felwort, 30g of astragali radix, 50g of ligusticum wallichii, 30g of glossy privet fruit, 30g of cortex dictamni and 35g of radix sophorae flavescentis. The traditional Chinese medicine is reasonable in compatibility of medicines, easy to prepare, low in cost, convenient to take, free from toxic and side effects, good in curative effect and short in course of treatment, has the effects of eliminating vitiligo, preventing vitiligo expansion and the like and has an obvious effect of treating the leucoderma; the effective rate reaches 97.47 percent.
Description
Technical field
The present invention relates to technical field of Chinese medicines, specifically one treats leukodermic Chinese medicine.
Background technology
Vitiligo is a kind of common posteriority, circumscribed depigmentation dermatoses, can betide any age, be more common in child and youth.Primary disease often has family history, has family's genetic predisposition.In addition, lower relevant with copper, zinc ion content in body.Primary disease is relevant with various autoimmune disease, as some patients with vitiligo or its relatives, hyperthyroidism can be associated with and go down, diabetes etc.; The organ specific antibody existence of thyroid, stomach, adrenal tissue is found in the blood of some patient.Patient is many to increase with perspiration, and performance temperature increases, the diseases such as prolonged bleeding time, the limitation decolouring speckle do not waited sized by disease damage, clear-cut margin, and around with healthy skin intersection, color of the leather is denseer; Kainogenesis infringement is common around temporary inflammatory halo, number or single-shot or multiple, and can mutually merge in flakes, affected part hair can bleach, and without any subjective symptoms, after Exposure to Sunlight, damaging part has bright gargalesthesia.Belong to blood deficiency and blood stasis wind-engaging person as the pathogenetic reason of vitiligo disease more.
At present, method and the medicine for the treatment of this disease are a lot, but can not reach desirable effect, the such as Therapeutic Method such as " laser ", " skin-grafting ", " freezing ", and not only weak curative effect, returns skin and leave scar; Some medicine is as patent medicine: speckle removing ball, remove Bai Su, white macula tincture etc., the existence of these medicines takes effect slowly, the course for the treatment of is long, the shortcomings such as the low and relapse rate of cure rate is high, some medicines also have irritated and slight toxic reaction, also the medicine had easily causes the side effect such as liver,kidney,spleen enlargement, brings misery to patient.
Summary of the invention
The present invention is directed to the deficiencies in the prior art, according to theory of Chinese medical science, by drug screening and the clinical verification repeatedly of several years, provide a kind of compatibility reasonable, expense is low, taking convenience, the leukodermic Chinese medicine of the treatment had no side effect.
Technical scheme of the present invention is: one treats leukodermic Chinese medicine, it is characterized in that the weight ratio of material medicine is: Herba Ecliptae 90 grams, Radix Angelicae Sinensis 60 grams, the Radix Angelicae Dahuricae 60 grams, Fructus Psoraleae 45 grams, Radix Gentianae 50 grams, Radix Astragali 30 grams, Rhizoma Chuanxiong 50 grams, Fructus Ligustri Lucidi 30 grams, Cortex Dictamni 30 grams, Radix Sophorae Flavescentis 35 grams.
Herba Ecliptae in the present invention: sweet in the mouth, acid, cold in nature; Return kidney, Liver Channel; There is nourishing the liver and kidney, effect of cooling blood for hemostasis; For odontoseisis, early whitening of beard and hair, vertigo and tinnitus, the acid of waist knee joint, YinXuXueRe, haematemesis, blood nosebleed, hematuria, dysentery, metrostaxis, traumatic hemorrhage.Radix Angelicae Sinensis: sweet in the mouth, pungent, warm in nature; Return liver, the heart, spleen channel; Having enriches blood invigorates blood circulation, menstruction regulating and pain relieving, effect of loosening bowel to relieve constipation.The Radix Angelicae Dahuricae: acrid in the mouth, warm in nature; Return stomach, large intestine, lung meridian; There is the cold expelling that induces sweat, wind-expelling pain-stopping, clearing the nasal passage, dampness leukorrhagia stopping, effect of detumescence and apocenosis; For controlling headache, supraorbital bone pain, toothache, nasal sinusitis, cold-damp is suffered from abdominal pain, hemorrhoidal hamorrhage anal fistula, leucorrhea with red and white discharge, ulcer sores, skin pruritus due to dryness, scabies.Fructus Psoraleae: acrid in the mouth, hardship, warm in nature; Return kidney, pericardium, spleen, stomach, lung meridian; There is effect of reinforcing the kidney and supporting YANG, controlling nocturnal emission with astringent drugs reducing urination, warm spleen antidiarrheal, helping inspiration to relieve asthma.Radix Gentianae: bitter in the mouth, cold in nature; Return liver, gallbladder meridian; There is heat clearing and damp drying, effect of eliminating pathogen in the liver arresting convulsion; Be used for the treatment of jaundice due to damp-heat, urine leaching pain, swelling of the vulva pudendal pruritus, damp-heat vaginal discharge, the feeling of fullness in the head headache of liver and gall excess-fire, conjunctival congestion and swelling pain, deaf ear swells, hypochondriac pain bitter taste, calentura convulsion with spasms.Radix Astragali: sweet in the mouth, slightly warm in nature; Return lung, spleen, liver, kidney channel; There is effect that benefiting QI for strengthening the superficies, tonifying the lung spleen invigorating, arresting sweating are admittedly de-, wind dispelling fortune is malicious; There is invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, effect of expelling pus and promoting granulation, inducing diuresis to remove edema.Rhizoma Chuanxiong: acrid in the mouth, warm in nature; Return liver, gallbladder, pericardium channel; There is effect of blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping.Fructus Ligustri Lucidi: sweet in the mouth, hardship, cool in nature; Return liver, kidney channel; There is tonifying liver kidney yin, effect of crow palpus improving eyesight.Cortex Dictamni: bitter in the mouth, salty, cold in nature; Return spleen channel; Lung meridian; Small intestine meridian; Stomach warp; Urinary bladder channel; There is heat clearing and damp drying; Dispelling wind for relieving itching; Effect of removing toxic substances; Cure mainly the rubella caused by wind heat noxious dampness; Eczema; Scabies; Jaundice; Damp-heat arthralgia.Radix Sophorae Flavescentis: bitter in the mouth, cold in nature; Return liver, kidney, large intestine, small intestine meridian, bladder, heart channel, urinary bladder channel; There is effect of heat clearing and damp drying: extensive use and multiple humidifier fever, as damp-heat dysentery external can decoct soup washout, for hemorrhoid, women gynecological.The present invention has nourishing the liver and kidney, enriches blood and invigorates blood circulation, and induce sweat cold expelling, heat clearing and damp drying, effect of wind-expelling pain-stopping.
Get above-mentioned raw materials medicine, after conventional Preparation process, grind to the powder altogether by the weight ratio of its material medicine, collection good seal, takes 3 every day, each 8g, warm water delivery service.Within 10 days, be a course for the treatment of, two courses for the treatment of can be used in conjunction.
Compatibility of the present invention is reasonable, and easily prepare, expense is low, and taking convenience has no side effect, good effect, short treating period, has elimination white macula, stops the effects such as white macula expansion, and have remarkable efficacy to treatment vitiligo, effective percentage reaches 97.47%.
Detailed description of the invention:
Embodiment 1: one treats leukodermic Chinese medicine, the weight ratio of its raw material is: Herba Ecliptae 90 grams, Radix Angelicae Sinensis 60 grams, the Radix Angelicae Dahuricae 60 grams, Fructus Psoraleae 45 grams, Radix Gentianae 50 grams, Radix Astragali 30 grams, Rhizoma Chuanxiong 50 grams, Fructus Ligustri Lucidi 30 grams, Cortex Dictamni 30 grams, Radix Sophorae Flavescentis 35 grams.Get above-mentioned raw materials medicine, after conventional Preparation process, grind to the powder altogether by the weight ratio of its material medicine, collection good seal, takes 3 every day, each 8g, warm water delivery service.Within 10 days, be a course for the treatment of, two courses for the treatment of can be used in conjunction.
One is treated leukodermic Clinical Action of Traditional Chinese Drugs and is summed up:
One, clinical criteria:
Leukodermic clinical manifestation is: the skin at any position of health all can occur, and resistance originates from easy sunlight and irradiates and damage by friction portion, as inside facial area, cervical region, trunk and extremity, lip, labia, glans penis and foreskin, mucosa also can involve.Major part leukasmus is symmetrical, also has some patients white macula to distribute along nerve segment.Skin lesion be locality depigmentation speckle, milky, from fingernail to coin size, circular, oval or irregular shape.White macula place hair also can bleach.In progressive stage, decolouring speckle is divided a word with a hyphen at the end of a line to normal skin, and development is very fast, and has isomorphic response, namely can form secondary vitiligo after pressure, friction, wound.
Can three types be divided according to leukoderma scope and distribution:
1, limitation: skin lesion is confined to a position, can be divided into again: (1) segmental pattern: skin lesion distributes by dermatomere; (2) mucosal pattern: only involve mucosa.
2, general hair style: the most common, shows as skin lesion and is distributed widely in body surface, can be divided into:
(1) homeliness type: skin lesion is dispersed in and is distributed in body surface many places;
(2) face acra type: skin lesion is distributed in face and far-end of limb;
(3) mixed type: above-mentioned several various combination forms, as face acra type+segmental pattern etc.
3, whole body type: whole skin all decolours completely or almost, also has hair to bleach.
Two, the selection of case
Leukodermic sickness rate is with area, the ethnic group colour of skin and different, and the darker people's sickness rate of general colour is higher.In population of China, prevalence is about 0.1-2%, and M-F is roughly equal, all can fall ill from newborn baby to old age, but is many with teenager.Record according to interrelated data: age of onset 10-30 year in the majority, account for sum 62.65%, women's age of onset comparatively male does sth. in advance about 5 years.For this reason, the selection of case goes to a doctor patient for all cases with door rash.
Three, curative effect determinate standard
The vitiligo curative effect determinate standard (Chen Qin edits " research and development of Chinese medicine cosmetic health product " China Medical Science Press version in 1999 the 228th page) that the present invention adopts is:
(1) fully recover: white macula disappears completely, histopathology of skin checks normal;
(2) effective: white macula more than 50% disappears, and white macula disappearance portion of tissue pathological examination is normal;
(3) effective: white macula disappearance person accounts for the 20-50% of former white spot area, or in white macula, see there is comparatively polychrom island;
(4) invalid: unchanged or white macula expansion before and after treatment.
Four, therapeutic effect: through clinical conditions patients with vitiligo 79 example, male 36 example, women 43 example, the age be 20-50 year.After taking 1-2 of the present invention course for the treatment of, patient skin white macula disappears in various degree or fully recovers, and patient is without any untoward reaction, and three large routine tests and hepatic and renal function detect and do not reveal any abnormalities.58 examples of fully recovering in 79 routine patients account for 73.42%, and effective 15 examples account for 18.99%, and effective 4 examples account for 5.06%, and invalid 2 examples account for 2.53%, and total effective rate reaches 97.47%.
Five, model case
1, Huang, man, 26 years old, time medical, disease was seen: white macula appears in arm, back many places, takes Chinese medicine of the present invention, and check after two courses for the treatment of, white macula disappears completely, and histopathology of skin checks normal, clinical recovery.
2, Tang, female, 39 years old, time medical, disease was seen: on face, arm, back, lower limb, white macula appears in many places, takes Chinese medicine of the present invention, remission after two courses for the treatment of, and continue to take two courses for the treatment of, symptom is almost recovered.
3, together certain, female, 44 years old, health was more weak, and white macula appears in medical Shi Zhengjian face, lower limb, and take Chinese medicine of the present invention, after the course for the treatment of, symptom alleviates, and check after taking again a course for the treatment of continuously, symptom disappears all, recovery from illness.
Claims (1)
1. treat a leukodermic Chinese medicine, it is characterized in that the weight ratio of material medicine is: Herba Ecliptae 90 grams, Radix Angelicae Sinensis 60 grams, the Radix Angelicae Dahuricae 60 grams, Fructus Psoraleae 45 grams, Radix Gentianae 50 grams, Radix Astragali 30 grams, Rhizoma Chuanxiong 50 grams, Fructus Ligustri Lucidi 30 grams, Cortex Dictamni 30 grams, Radix Sophorae Flavescentis 35 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310727750.4A CN103705605B (en) | 2013-12-16 | 2013-12-16 | Traditional Chinese medicine for treating leucoderma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310727750.4A CN103705605B (en) | 2013-12-16 | 2013-12-16 | Traditional Chinese medicine for treating leucoderma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103705605A CN103705605A (en) | 2014-04-09 |
| CN103705605B true CN103705605B (en) | 2015-07-15 |
Family
ID=50399191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310727750.4A Expired - Fee Related CN103705605B (en) | 2013-12-16 | 2013-12-16 | Traditional Chinese medicine for treating leucoderma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103705605B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104474298A (en) * | 2014-11-21 | 2015-04-01 | 王正琦 | Traditional Chinese medicine for treating vitiligo |
| CN104958466A (en) * | 2015-08-05 | 2015-10-07 | 王凯琳 | Medicine for treating vitiligo |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1047942C (en) * | 1993-08-17 | 2000-01-05 | 邓锦煌 | Vitiligo tincture |
| CN1171250A (en) * | 1996-07-23 | 1998-01-28 | 温苹 | Powder for treating leucoderma, eczema and acne |
| CN1181970A (en) * | 1997-11-14 | 1998-05-20 | 黄国泉 | Externally painted medicine for vitiligo and its preparation |
| CN101099799B (en) * | 2006-07-08 | 2012-10-31 | 成爱华 | Medicine for treating leucoderma by melanin regeneration |
| CN102362950A (en) * | 2011-06-15 | 2012-02-29 | 王莲芬 | Traditional Chinese medicine for treating leucoderma |
| CN102793782A (en) * | 2012-09-10 | 2012-11-28 | 邵登银 | Externally applied ointment for leucoderma |
| CN103721208A (en) * | 2012-10-11 | 2014-04-16 | 钱国祥 | Eclipta prostrata L health care wine used for treating alopecia areata |
| CN103393903B (en) * | 2013-08-06 | 2015-02-25 | 董云 | Medicament for treating leucoderma |
-
2013
- 2013-12-16 CN CN201310727750.4A patent/CN103705605B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103705605A (en) | 2014-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100551422C (en) | A kind of endo-medicine for the treatment of intervertebral disk hernia | |
| CN104958484A (en) | traditional Chinese medicine unguent for promoting blood circulation to remove meridian obstruction and preparing method of traditional Chinese medicine unguent | |
| CN100367985C (en) | Chinese prepared medicine for treating bone pain | |
| CN101564521A (en) | External plaster for treating hyperplasia of mammary glands | |
| CN102793883B (en) | Plaster for treating intervertebral disc protrusion and cervical spondylosis | |
| CN104940727A (en) | Paste for treating rhinitis and preparation method thereof | |
| CN103705751B (en) | Chinese medicine composition being used for the treatment of lumbago due to pathogenic wind-dampness and preparation method thereof | |
| CN102836409B (en) | Traditional Chinese medicine for treating postpartum lochiorrhea and preparation method | |
| CN102114217B (en) | Traditional Chinese medicine fumigant for treating tinea capitis | |
| CN104069474B (en) | Traditional Chinese medicine composition for treating seborrheic alopecia and preparation method thereof | |
| CN110314216A (en) | It is a kind of to treat Bones and joints, plaster of soft tissue disease pain and preparation method thereof | |
| CN103041023A (en) | Traditional Chinese medicine composition for treating kidney deficiency infertility of women | |
| CN103599195B (en) | Traditional Chinese medicine composition for treating leucoderma | |
| CN103705605B (en) | Traditional Chinese medicine for treating leucoderma | |
| CN104161823B (en) | A kind of Chinese medicine for the treatment of aseptic necrosis of femoral head | |
| CN102430097A (en) | Chinese medicine for treating vitiligo | |
| CN102579975B (en) | Traditional Chinese medicine mixture for treating psoriasis | |
| CN104784346A (en) | Pruritus treating traditional Chinese medicine lotion preparation method | |
| CN103550383A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN103223078A (en) | Traditional Chinese medicine used for treating knee osteoarthritis through iontophoresis | |
| CN104324097A (en) | Externally-applied traditional Chinese medicine composition for treating pain arthralgia type knee osteoarthritis | |
| CN105726853A (en) | Traditional Chinese medicine preparation for treating angina pectoris and preparation method thereof | |
| CN103656460A (en) | Traditional Chinese medicinal composition for treating diabetes | |
| CN102861197A (en) | Traditional Chinese medicine composition for treating injuries from falls, fractures, contusions and strains | |
| CN103845583B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of chronic hepatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150715 Termination date: 20151216 |
|
| EXPY | Termination of patent right or utility model |